MedX Health Corp Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

MedX Health Corp cash flow conversion efficiency. Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K ≈ $-497.43K USD) by net assets (CA$-10.02 Million ≈ $-7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of MedX Health Corp (2013–2024)

Cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of MedX Health Corp for real-time trading data and today's change.

MedX Health Corp Cash Flow Conversion Ratio Explained

MedX Health Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

MedX Health Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency. Also see MDX market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cuscapi Berhad KLSE:0051	0.081x
Mainz Biomed BV NASDAQ:MYNZ	-6.957x
Sky Quarry Inc NASDAQ:SKYQ	-0.295x
Tian An Australia Ltd AU:TIA	0.083x
Agrogeneration PA:ALAGR	-0.030x
Nala Digital Commerce Ltd TA:NALA	-0.080x
Excite Technology Services Ltd AU:EXT	0.446x
Electronic City Indonesia Tbk JK:ECII	-0.015x

Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)

The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. Review MDX free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-8.52 Million ≈ $-6.17 Million	CA$-2.51 Million ≈ $-1.82 Million	0.295x	-38.53%
2023-12-31	CA$-7.14 Million ≈ $-5.17 Million	CA$-3.42 Million ≈ $-2.48 Million	0.479x	+21.14%
2022-12-31	CA$-7.08 Million ≈ $-5.12 Million	CA$-2.80 Million ≈ $-2.03 Million	0.396x	-68.21%
2021-12-31	CA$-3.63 Million ≈ $-2.63 Million	CA$-4.52 Million ≈ $-3.27 Million	1.244x	-11.46%
2020-12-31	CA$-2.07 Million ≈ $-1.50 Million	CA$-2.91 Million ≈ $-2.10 Million	1.405x	+204.09%
2019-12-31	CA$-2.87 Million ≈ $-2.07 Million	CA$-1.32 Million ≈ $-958.33K	0.462x	-72.62%
2018-12-31	CA$-1.54 Million ≈ $-1.12 Million	CA$-2.61 Million ≈ $-1.89 Million	1.688x	+72.37%
2017-12-31	CA$-1.50 Million ≈ $-1.09 Million	CA$-1.47 Million ≈ $-1.06 Million	0.979x	+34.25%
2016-12-31	CA$-1.83 Million ≈ $-1.32 Million	CA$-1.33 Million ≈ $-963.12K	0.729x	+225.13%
2015-12-31	CA$-2.39 Million ≈ $-1.73 Million	CA$-536.53K ≈ $-388.12K	0.224x	-41.31%
2014-12-31	CA$-2.26 Million ≈ $-1.64 Million	CA$-864.08K ≈ $-625.06K	0.382x	+814.58%
2013-12-31	CA$-3.40 Million ≈ $-2.46 Million	CA$-141.94K ≈ $-102.68K	0.042x	--

About MedX Health Corp

V:MDX Canada Medical Devices

Market Cap

$9.49 Million

CA$13.12 Million CAD

Market Cap Rank

#27042 Global

#1107 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.07

All Time High

CA$0.30